Loss of placental growth factor protects mice against vascular permeability in pathological conditions (Q45888226)

17 December 2017

title

Loss of placental growth factor protects mice against vascular permeability in pathological conditions (English)

1 reference

17 December 2017

author

Aernout Luttun

1

1 reference

17 December 2017

Peter Carmeliet

9

object named as

Peter Carmeliet

1 reference

17 December 2017

10

Lieve Moons

1 reference

17 December 2017

author name string

Koen Brusselmans

2

1 reference

17 December 2017

Hideharu Fukao

3

1 reference

17 December 2017

Marc Tjwa

4

1 reference

17 December 2017

Shigeru Ueshima

5

1 reference

17 December 2017

Jean-Marc Herbert

6

1 reference

17 December 2017

Osamu Matsuo

7

1 reference

17 December 2017

Désiré Collen

8

1 reference

17 December 2017

language of work or name

English

0 references

publication date

1 July 2002

1 reference

17 December 2017

Biochemical and Biophysical Research Communications

published in

1 reference

17 December 2017

volume

295

1 reference

17 December 2017

issue

2

1 reference

17 December 2017

page(s)

428-434

1 reference

17 December 2017

Hypothetical roles of angiogenesis, osmotic swelling, and ischemia in high-altitude cerebral edema

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900677-0

Vascular leakage stimulates phenotype alteration in ocular cells, contributing to the pathology of proliferative vitreoretinopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900677-0

Allergen challenge-induced extravasation of plasma in mouse airways.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900677-0

Vascular endothelial growth factor/vascular permeability factor in the pathogenesis of primary effusion lymphomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900677-0

Role of vascular endothelial growth factor in ovarian cancer: inhibition of ascites formation by immunoneutralization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900677-0

Sepsis/septic shock: participation of the microcirculation: an abbreviated review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900677-0

Vascular leak syndrome: a side effect of immunotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900677-0

Increased microvascular density and enhanced leukocyte rolling and adhesion in the skin of VEGF transgenic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900677-0

Lung overexpression of the vascular endothelial growth factor gene induces pulmonary edema.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900677-0

Lower-extremity edema associated with gene transfer of naked DNA encoding vascular endothelial growth factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900677-0

VEGF antagonism reduces edema formation and tissue damage after ischemia/reperfusion injury in the mouse brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900677-0

Selective requirement for Src kinases during VEGF-induced angiogenesis and vascular permeability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900677-0

Vascular endothelial growth factor signals endothelial cell production of nitric oxide and prostacyclin through flk-1/KDR activation of c-Src

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900677-0

Src deficiency or blockade of Src activity in mice provides cerebral protection following stroke

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900677-0

Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900677-0

Placenta growth factor and vascular endothelial growth factor are co-expressed during early embryonic development.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900677-0

Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900677-0

Image analysis quantification of the Miles assay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900677-0

Effects of WEB 2086, a novel antagonist of platelet activating factor, in active and passive anaphylaxis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900677-0

Modulation of hemodynamic and vascular filtration changes in diabetic rats by dietary myo-inositol.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900677-0

Neurogenic inflammation in the chicken (Gallus gallus var domesticus).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900677-0

Expression of vascular permeability factor (vascular endothelial growth factor) by epidermal keratinocytes during wound healing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900677-0

Cell phenotype as a target of drug therapy in chronic inflammatory diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900677-0

The bronchial microcirculation in asthma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900677-0

Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900677-0

A recombinant mutant vascular endothelial growth factor-C that has lost vascular endothelial growth factor receptor-2 binding, activation, and vascular permeability activities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900677-0

A novel type of vascular endothelial growth factor, VEGF-E (NZ-7 VEGF), preferentially utilizes KDR/Flk-1 receptor and carries a potent mitotic activity without heparin-binding domain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900677-0

VEGF increases BMEC monolayer permeability by affecting occludin expression and tight junction assembly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900677-0

A permissive role for tumor necrosis factor in vascular endothelial growth factor-induced vascular permeability.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900677-0

Predominant role of endothelial nitric oxide synthase in vascular endothelial growth factor-induced angiogenesis and vascular permeability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900677-0

Vascular endothelial growth factor (VEGF)-induced retinal vascular permeability is mediated by intercellular adhesion molecule-1 (ICAM-1).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900677-0

Vascular endothelial growth factor/vascular permeability factor enhances vascular permeability via nitric oxide and prostacyclin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900677-0

Vascular endothelial growth factor-induced retinal permeability is mediated by protein kinase C in vivo and suppressed by an orally effective beta-isoform-selective inhibitor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900677-0

Heparin-binding protein (HBP/CAP37): A missing link in neutrophil-evoked alteration of vascular permeability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900677-0

Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900677-0

Angiopoietin-1 protects the adult vasculature against plasma leakage.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900677-0

Preclinical and phase 1A clinical evaluation of an anti-VEGF pegylated aptamer (EYE001) for the treatment of exudative age-related macular degeneration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900677-0

Effect of local anti-VEGF antibody treatment on tumor microvessel permeability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900677-0

Edema and vascular permeability in cerebral ischemia: comparison between ischemic neuronal damage and infarction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900677-0

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0006-291X(02)00677-0

1 reference

17 December 2017

PubMed ID

12150967

1 reference

17 December 2017